Sun Pharma, Lupin recall products from the world's largest medicines market
Sun, Jan 16, 2022 1:10 PM

Sun Pharma, Lupin recall products from the world's largest medicines market

A Flip by Flipitnews
Get it on Google Play
Sun Pharma and Lupin are recalling products from the world's largest market for medicines, the United States for different reasons. According to USFDA, Sun Pharma is recalling 696 bottles of Pregabalin capsules (50 mg), used for the treatment of epilepsy, anxiety, and nerve pain, in the US market. Lupin is recalling 50,832 bottles of Gatifloxacin Ophthalmic Solution.

More great flips

Big movers on the D-Street!

Big movers on the D-Street!

Equity indices ended lower on Tuesday as a fag-end sell-off wiped out early gains amid a mixed trend in global markets. The 30-share Sensex declined 188 points to settle at 74,482 and the Nifty dipped 38 points to finish at 22,604. Stocks that were in focus include names like Star Health, which rose 1.69%, M&M, which increased 4.63%, and Tata Chemicals, whose shares declined 2.49% on Thursday.

Open Flip
Think twice about selling in May and going away

Think twice about selling in May and going away

General elections are feared to induce sharp swings in equities. ET spoke to four analysts on whether the seasonality factor of the 'Sell in May' adage could be valid this time. While volatility is anticipated, these analysts do not see a disruption in the recent bullish trend. They expect bank stocks to drive the market, while advising against leveraged bets in equities for now.

Open Flip
Kotak Mahindra Bank, Havells and more: Thursday's top brokerage calls

Kotak Mahindra Bank, Havells and more: Thursday's top brokerage calls

💰Nuvama has downgraded its rating on Kotak Mahindra Bank to 'reduce' with a target of ₹1,530 per share. 💰UBS has maintained a 'buy' rating on Havells with a target of ₹2,040 per share. 💰Jefferies has maintained a 'hold' rating on Kotak Mahindra Bank with a target of ₹1,970 per share. 💰DAM Capital has upgraded its rating on M&M to 'buy' with a target of ₹2,550 per share.

Open Flip

Join our Smart Investment Community

More than 1 Million users are using FlipItMoney to stay updated about the business and finance world! Join FlipItMoney now and take smart investment decisions!
Icon